26 Patients Randomized. $577 Each.
A ZO Skin Health study site enrolled 26 participants through a targeted recruitment campaign, with every dollar accountable to a contractual randomization commitment. The lowest cost per patient in the Clinical Enroll portfolio.
Check if your study qualifies26
Patients Randomized
$15,000
Campaign Investment
$577
Cost Per Randomized Patient
Closing an Enrollment Gap on a Protocol That Could Not Miss Its Timeline
A ZO Skin Health study site needed to reach its enrollment target within a fixed study window. The existing patient pipeline could not sustain the pace the protocol required.
In-house outreach had been considered but not resourced. Commercially available recruitment vendors offered campaign deliverables tied to activity, not to the outcome the site needed: randomized patients. The cost structure made no distinction between campaigns that succeeded and campaigns that did not.
The site required a partner whose financial commitment matched the commitment the site was making to the sponsor.
Feasibility First. IRB-Ready Campaign. Pre-Screened Referrals.
Feasibility confirmed a viable patient population within the site's geographic catchment area. Clinical Enroll developed an IRB-ready campaign, deployed across condition-targeted digital channels, with pre-screening built into the referral process before any patient reached the site's coordinator team. The randomization commitment was formalized in contract before launch.
26 Randomized Patients. $577 Per Randomized Patient.
The campaign delivered 26 randomized patients against a $15,000 investment, a cost per randomized patient of $577. This is the lowest cost per randomized patient in the Clinical Enroll portfolio across all published engagements.
The randomization commitment in the contract meant the site carried no financial exposure if the campaign fell short. The contractual structure was designed around the outcomes the site could report to its sponsor and account for on its own P&L.
Find out if your study qualifies for the same commitment.
Not every study is a fit. Clinical Enroll conducts a feasibility evaluation before extending a randomization commitment. If your protocol and patient population support it, you will receive a campaign proposal with a contractual outcome guarantee, not a media budget and a projection.
All campaigns developed for IRB review and deployed in accordance with FDA guidance on clinical trial advertising.